» Articles » PMID: 39149760

Development and Validation of a Predictive Model for Submucosal Fibrosis in Patients with Early Gastric Cancer Undergoing Endoscopic Submucosal Dissection: Experience from a Large Tertiary Center

Overview
Journal Ann Med
Publisher Informa Healthcare
Specialty General Medicine
Date 2024 Aug 16
PMID 39149760
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Submucosal fibrosis is associated with adverse events of endoscopic submucosal dissection (ESD). The present study mainly aimed to establish a predictive model for submucosal fibrosis in patients with early gastric cancer (EGC) undergoing ESD.

Methods: Eligible patients with EGC, identified at Qilu Hospital of Shandong University from April 2013 to December 2023, were retrospectively included and randomly split into a training set and a validation set in a 7:3 ratio. Logistic regression analyses were used to pinpoint the risk factors for submucosal fibrosis. A nomogram was developed and confirmed using receiver operating characteristic (ROC) curves, calibration plots, Hosmer-Lemeshow (H-L) tests, and decision curve analysis (DCA) curves. Besides, a predictive model for severe submucosal fibrosis was further conducted and tested.

Results: A total of 516 cases in the training group and 220 cases in the validation group were recruited. The nomogram for submucosal fibrosis contained the following items: tumour location (long axis), tumour location (short axis), ulceration, and biopsy pathology. ROC curves showed high efficiency with an area under the ROC of 0.819 in the training group, and 0.812 in the validation group. Calibration curves and H-L tests indicated good consistency. DCA proved the nomogram to be clinically beneficial. Furthermore, the four items were also applicable for a nomogram predicting severe fibrosis, and the model performed well.

Conclusion: The predictive models, initially constructed in this study, were validated as convenient and feasible for endoscopists to predict submucosal fibrosis and severe fibrosis in patients with EGC undergoing ESD.

References
1.
Zhuang X, Xu M, Chen Z, Wang J, Qian K, Wang S . Predictors for Submucosal Fibrosis in Patients With Superficial Squamous Esophageal Neoplasia Undergoing Endoscopic Submucosal Dissection. Clin Transl Gastroenterol. 2020; 11(8):e00188. PMC: 7410034. DOI: 10.14309/ctg.0000000000000188. View

2.
Speca S, Giusti I, Rieder F, Latella G . Cellular and molecular mechanisms of intestinal fibrosis. World J Gastroenterol. 2012; 18(28):3635-61. PMC: 3406417. DOI: 10.3748/wjg.v18.i28.3635. View

3.
Chung I, Lee J, Lee S, Kim S, Cho J, Cho W . Therapeutic outcomes in 1000 cases of endoscopic submucosal dissection for early gastric neoplasms: Korean ESD Study Group multicenter study. Gastrointest Endosc. 2009; 69(7):1228-35. DOI: 10.1016/j.gie.2008.09.027. View

4.
Ma X, Zhang Q, Zhu S, Zhang S, Sun X . Risk Factors and Prediction Model for Non-curative Resection of Early Gastric Cancer With Endoscopic Resection and the Evaluation. Front Med (Lausanne). 2021; 8:637875. PMC: 8160094. DOI: 10.3389/fmed.2021.637875. View

5.
Urban M, Manenti L, Vaglio A . Fibrosis--A Common Pathway to Organ Injury and Failure. N Engl J Med. 2015; 373(1):95-6. DOI: 10.1056/NEJMc1504848. View